These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26445483)

  • 21. A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey.
    Kyari F; Entekume G; Rabiu M; Spry P; Wormald R; Nolan W; Murthy GV; Gilbert CE;
    BMC Ophthalmol; 2015 Dec; 15():176. PubMed ID: 26653326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maladaptive coping strategies and glaucoma progression.
    Freeman EE; Lesk MR; Harasymowycz P; Desjardins D; Flores V; Kamga H; Li G
    Medicine (Baltimore); 2016 Aug; 95(35):e4761. PubMed ID: 27583929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of early visual loss following glaucoma-filtering surgery in eyes with split fixation.
    Balekudaru S; George R; Panday M; Singh M; Neog A; Lingam V
    J Glaucoma; 2014; 23(4):211-8. PubMed ID: 24522104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of Binocular Visual Field Loss Derived from Large-Scale Patient Data from Glaucoma Clinics.
    Hu S; Smith ND; Saunders LJ; Crabb DP
    Ophthalmology; 2015 Dec; 122(12):2399-406. PubMed ID: 26391463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of focal lamina cribrosa defect on glaucomatous visual field progression.
    Faridi OS; Park SC; Kabadi R; Su D; De Moraes CG; Liebmann JM; Ritch R
    Ophthalmology; 2014 Aug; 121(8):1524-30. PubMed ID: 24697910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients have two eyes!: binocular versus better eye visual field indices.
    Asaoka R; Crabb DP; Yamashita T; Russell RA; Wang YX; Garway-Heath DF
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):7007-11. PubMed ID: 21810985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vision impairment and major causes of vision loss impacts on vision-specific functioning independent of socioeconomic factors.
    Chiang PP; Zheng Y; Wong TY; Lamoureux EL
    Ophthalmology; 2013 Feb; 120(2):415-22. PubMed ID: 23149127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of the binocular visual field with patient assessment of vision.
    Jampel HD; Friedman DS; Quigley H; Miller R
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1059-67. PubMed ID: 11923247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma.
    Gracitelli CP; Abe RY; Tatham AJ; Rosen PN; Zangwill LM; Boer ER; Weinreb RN; Medeiros FA
    JAMA Ophthalmol; 2015 Apr; 133(4):384-90. PubMed ID: 25569808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
    Parrish RK
    Trans Am Ophthalmol Soc; 1996; 94():919-1028. PubMed ID: 8981717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of various machine learning methods to predict vision-related quality of life from visual field data and visual acuity in patients with glaucoma.
    Hirasawa H; Murata H; Mayama C; Araie M; Asaoka R
    Br J Ophthalmol; 2014 Sep; 98(9):1230-5. PubMed ID: 24795333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery.
    Talajic JC; Agoumi Y; Gagné S; Moussally K; Harissi-Dagher M
    Am J Ophthalmol; 2012 Feb; 153(2):267-274.e1. PubMed ID: 21982110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avoidable sight loss from glaucoma: is it unavoidable?
    Kotecha A; Fernandes S; Bunce C; Franks WA
    Br J Ophthalmol; 2012 Jun; 96(6):816-20. PubMed ID: 22493037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival of central visual field in end-stage glaucoma.
    Much JW; Liu C; Piltz-Seymour JR
    Ophthalmology; 2008 Jul; 115(7):1162-6. PubMed ID: 18067965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical success factors in awareness of and choice towards low vision rehabilitation.
    Fraser SA; Johnson AP; Wittich W; Overbury O
    Ophthalmic Physiol Opt; 2015 Jan; 35(1):81-9. PubMed ID: 25376530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical method to assess the effect of visual loss on the ability to perform activities of daily living.
    Wei H; Sawchyn AK; Myers JS; Katz LJ; Moster MR; Wizov SS; Steele M; Lo D; Spaeth GL
    Br J Ophthalmol; 2012 May; 96(5):735-41. PubMed ID: 22241927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse glaucomatous structural and functional damage in the hemifield without significant pattern loss.
    Grewal DS; Sehi M; Greenfield DS
    Arch Ophthalmol; 2009 Nov; 127(11):1442-8. PubMed ID: 19901209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing self-reported vision-related activity limitation in the visually impaired.
    Tabrett DR; Latham K
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5293-302. PubMed ID: 21613370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual function and quality of life in Korean patients with glaucoma.
    Nah YS; Seong GJ; Kim CY
    Korean J Ophthalmol; 2002 Dec; 16(2):70-4. PubMed ID: 12546442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.